These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 30727764)

  • 21. The organism is the product.
    Kelly J
    ACS Synth Biol; 2012 Jan; 1(1):4-5. PubMed ID: 23651004
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The New Age of Cell-Free Biology.
    Noireaux V; Liu AP
    Annu Rev Biomed Eng; 2020 Jun; 22():51-77. PubMed ID: 32151150
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [System biology and synthetic biology modify drug discovery and development].
    Haiech J; Ranjeva R; Kilhoffer MC
    Med Sci (Paris); 2012 Feb; 28(2):207-12. PubMed ID: 22377310
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prospective Technology Assessment of Synthetic Biology: Fundamental and Propaedeutic Reflections in Order to Enable an Early Assessment.
    Schmidt JC
    Sci Eng Ethics; 2016 Aug; 22(4):1151-1170. PubMed ID: 26160061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthetic biology and its alternatives. Descartes, Kant and the idea of engineering biological machines.
    Kogge W; Richter M
    Stud Hist Philos Biol Biomed Sci; 2013 Jun; 44(2):181-9. PubMed ID: 23623436
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developing synthetic biology in Argentina: the Latin American TECNOx community as an alternative way for growth of the field.
    Nadra AD; Rodríguez PE; Grunberg R; Olalde LG; Sánchez IE
    Crit Rev Biotechnol; 2020 May; 40(3):357-364. PubMed ID: 32075446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Terraforming: synthetic biology's final frontier.
    Sleator RD; Smith N
    Arch Microbiol; 2019 Aug; 201(6):855-862. PubMed ID: 30929030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding health systems, health economies and globalization: the need for social science perspectives.
    Murray SF; Bisht R; Baru R; Pitchforth E
    Global Health; 2012 Aug; 8():30. PubMed ID: 22938504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic Biology: opportunities for Chilean bioindustry and education.
    Federici F; Rudge TJ; Pollak B; Haseloff J; Gutiérrez RA
    Biol Res; 2013; 46(4):383-93. PubMed ID: 24510141
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthetic biology: from "build-for-use" to commercialization].
    Zhao G
    Sheng Wu Gong Cheng Xue Bao; 2022 Nov; 38(11):4001-4011. PubMed ID: 37699671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Social sciences and synthetic biology: opportunities and constraints].
    Marris C
    Med Sci (Paris); 2013 May; 29 Spec No 2():61-4; discussion 65-8. PubMed ID: 23759500
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of risk assessments in the governance of genetically modified organisms in agriculture.
    Strand R
    J Hazard Mater; 2001 Sep; 86(1-3):187-204. PubMed ID: 11532366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Post-genomic science: cross-disciplinary and large-scale collaborative research and its organizational and technological challenges for the scientific research process.
    Welsh E; Jirotka M; Gavaghan D
    Philos Trans A Math Phys Eng Sci; 2006 Jun; 364(1843):1533-49. PubMed ID: 16766359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Q&A: Circuit capacity. Interview by Richard Saltus.
    Collins J
    Nature; 2012 Feb; 483(7387):S11. PubMed ID: 22378119
    [No Abstract]   [Full Text] [Related]  

  • 35. Exploring presentations of sustainability by US synthetic biology companies.
    Karabin J; Mansfield I; Frow EK
    PLoS One; 2021; 16(9):e0257327. PubMed ID: 34534242
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic biology confronts publics and policy makers: challenges for communication, regulation and commercialization.
    Bubela T; Hagen G; Einsiedel E
    Trends Biotechnol; 2012 Mar; 30(3):132-7. PubMed ID: 22119159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Grand challenges in space synthetic biology.
    Menezes AA; Montague MG; Cumbers J; Hogan JA; Arkin AP
    J R Soc Interface; 2015 Dec; 12(113):20150803. PubMed ID: 26631337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthetic biology: from mainstream to counterculture.
    Sleator RD
    Arch Microbiol; 2016 Sep; 198(7):711-3. PubMed ID: 27316777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [From human genome to man-made life: J. Craig Venter leads the life sciences].
    Sun M; Li Y; Gao GF
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):697-706. PubMed ID: 20815248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthetic Biology R&D Risks: Social-Institutional Contexts Matter!
    Wolfe AK; Campa MF; Bergmann RA; Stelling SC; Bjornstad DJ; Shumpert BL
    Trends Biotechnol; 2016 May; 34(5):353-356. PubMed ID: 26900006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.